IL23R and esophageal squamous cell carcinoma: Activation of the IL-23/IL-23R pathway facilitates radioresistance in ESCC by triggering Wnt-Notch-mediated G0/1 phase arrest, and that attenuation of this pathway may prove an effective pretreatment for radiation therapy [127].